Clinical Scorecard: Adoption of the 9th TNM Classification for Lung Cancer: Key Considerations for Radiologists
At a Glance
Category
Detail
Condition
Lung cancer staging and classification
Key Mechanisms
Updated TNM classification subdividing nodal (N2) and metastatic (M1c) categories to refine prognostic stratification
Target Population
Patients diagnosed with lung cancer at various stages
Care Setting
Radiology and multidisciplinary oncology care settings
Key Highlights
N2 category subdivided into N2a (single ipsilateral station) and N2b (multiple ipsilateral stations) reflecting distinct prognostic differences.
M1c category subdivided into M1c1 (multiple metastases in a single organ/system) and M1c2 (metastases in multiple organ systems).
Stage groupings IIA, IIB, IIIA, and IIIB reorganized based on new N2 and M1c subcategories, impacting clinical staging and treatment planning.
Guideline-Based Recommendations
Diagnosis
Use the 9th edition TNM classification for accurate anatomical staging of lung cancer.
Identify and report single versus multiple ipsilateral mediastinal lymph node stations (N2a vs N2b).
Distinguish between multiple metastases confined to a single organ/system (M1c1) and those involving multiple organ systems (M1c2).
Management
Incorporate updated staging information into multidisciplinary treatment planning.
Recognize that N2a and N2b subcategories have prognostic implications influencing therapeutic decisions.
Understand that M1c1 and M1c2 subcategories do not change stage IVB classification but may inform prognosis.
Monitoring & Follow-up
Radiological follow-up should consider the number and location of nodal stations and metastatic organ systems per the 9th TNM.
Ensure imaging reports explicitly state the TNM subcategories to guide clinical management.
Risks
Misclassification of nodal involvement (single vs multiple stations) may lead to inaccurate staging and suboptimal treatment.
Failure to differentiate M1c1 from M1c2 could obscure prognostic assessment.
Patient & Prescribing Data
Patients with lung cancer undergoing staging and treatment planning.
Refined TNM staging supports tailored multimodal treatment approaches, including surgery, systemic therapies, and localized treatments based on updated anatomical extent.
Clinical Best Practices
Familiarize radiology teams with the 9th edition TNM updates prior to implementation in 2025.
Report lymph node involvement by number of stations rather than total lymph nodes.
Clearly document metastatic burden by organ system involvement per new M1c subcategories.
Collaborate closely in multidisciplinary meetings to integrate updated staging into clinical decision-making.
The rising incidence and mortality of early-onset colorectal cancer (EOCRC), defined as disease occurring in patients younger than 50, has emerged as a clinically significant trend with implications for screening, diagnosis, and survivorship.
